Spotlight on

Artificial Intelligence (AI)

Artificial Intelligence (AI) is the simulation of human intelligence that arises when machines are programmed to mimic cognitive functions such as learning, problem solving, and decision making.

Our daily lives are now full of AI driven enhancements, from voice activated virtual assistants to predictive algorithms that shape our online interactions. The explosion in AI in recent years has redefined the boundaries of what technology can achieve, propelling us into an era where intelligent systems augment human capabilities to enhance efficiency, creativity, and problem solving, across a wide range of commercial sectors.  

In the software sector, AI streamlines processes, for example, by automated coding and bug detection. In the healthcare sector, AI facilitates diagnostics, personalized treatment plans, and drug discovery, ushering in an era of tailored medical solutions. In the automotive sector, AI underpins improvements in driver assistance features such as adaptive cruise control, lane-recognition, and collision avoidance. The future of AI holds exciting prospects, with continued advancements across these sectors and many more.  

We have deep AI expertise in these sectors

favicon-1

E-commerce and finance

favicon-1

digital security

favicon-1

Health & Bio / Pharma

favicon-1

Transport & Logistics

favicon-1

Quantum AI

favicon-1

AI Hardware

favicon-1

AI assisted design and technology

favicon-1

Agriculture

Why choose us?

  • We are a diverse and multidisciplinary team. Our powerful combination of cutting-edge technical knowledge and deep experience means clients get the right combination of skills. We build teams, picking the right people for your technical and commercial needs from across the firm. We are genuinely one team and are encouraged to work that way. It’s best for our clients.  

  • AI lives in a complex IP environment and we understand all aspects of it. We understand that open source, publications, trade secrets, patents and partnerships all have a role to play in the AI ecosystem, and we are used to helping navigate that. We work closely between our patent team and our legal team to help with issues around protection strategy, open sourcing, software licensing, and data driven collaborations.

  • We think on our feet.  Our focus is on tailoring our approach to what’s best for you. We know speed can often be key for example,  so we tailor our prosecution style accordingly. We don’t rely on letters and standard process, we call examiners, ask questions and push to shorten the prosecution timeline. Our commercial experience means we understand the pressures our clients face and act accordingly.

  • We lead the way in probing the boundaries of patent eligibility. We have been at the forefront of pushing the boundaries of what software can be patented for decades, and continue to do so in relation to AI-based technologies

  • We have a strong commercial focus. We seek to understand what our clients want to achieve, and make IP work for them. We have a wealth of experience in working closely with companies and serving as their “in-house” counsel, applying our knowledge and expertise to their commercial needs.

  • We thrive on new tech. We’re known for in working in brand new technologies right from the start and working with clients to figure out how to best to protect and leverage them.  As the forward-looking IP firm we’re passionate about progress and helping our clients maximise the potential this brings

  • We’re implementing AI in our own business. We’re excited by the potential of AI and have a strategy and action plan to implement AI into our firm.

  • We believe in the power of AI done right. As well as contributing to education on potentials and pitfalls of the technology, we are also actively looking at charities we can support in this space as part of our community programme where we donate 1% of profits to charity each year. 

Read our artificial intelligence blogs

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

by Alex Burns

Today, the Court of Appeal handed down its hotly-anticipated judgment in the Emotional Perception AI case, the first case heard at this level on the patentability of AI-based inventions ...

Quantum Technology in Denmark

Quantum Technology in Denmark

by Joshua Tall

Mewburn Ellis is excited to announce that we now have a part-time office at The BioInnovation Institute Foundation (BII) in Copenhagen, Denmark. The BII is a start-up incubator funded by the Novo ...

Living with artificial intelligence: can the law cope?

Living with artificial intelligence: can the law cope?

by Emma Kennaugh-Gallacher

As part of our Thought Leaders series, we explore the copyright issues arising from AI-generated content and the status in patent law of AI-generated inventions.

The HPV vaccine: the global success of prioritising women’s health

The HPV vaccine: the global success of prioritising women’s health

by Alice Jefferies

Let's talk about the HPV vaccine - a revolutionary drug and global strategy that proved how investing in and raising awareness about women's health benefits everyone.

How data changed our understanding and care of breast cancer

How data changed our understanding and care of breast cancer

by Camille Terfve

Breast cancer does not only affect women, but it mostly affects them1. Breast cancer is the most common cancer in the UK. Yet in England, about 3 in 4 women diagnosed with breast cancer will go on to ...

English Courts consider the patentability of AI

English Courts consider the patentability of AI

by Alex Burns

My colleague, Rebecca Frith and I viewed the Court of Appeal hearing in the Emotional Perception AI case on Tuesday and Wednesday this week. It is the first time that the patentability of AI has been ...

Learn More

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

Special Report

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. However, navigating this rapidly changing landscape can be challenging for those in charge of managing the IP associated with the innovations underpinning these changes.  

In this Special Report, we set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained from the data that will assist in designing better, more informed IP strategies.

DOWNLOAD THE REPORT
Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.

 

Subscribe now
Forward Magazines Overlapping 8